Immunoblots

17 Results Found

Helico Blot 2.1 (RUO)

The MP Diagnostics (MPD) HELICO BLOT 2.1 Western Blot kit assay is a qualitative assay for the detection of IgG antibodies to Helicobacter pylori (H. pylori) in human serum or plasma, with the added indication of current status. It is an improved version of HELICO BLOT 2.0 where in addition to bacterial lysate, there is a recombinant antigen with high predictive value for the indication of current H. pylori . The product is intended for use as a serological test for the detection of both current and past with H. pylori. Unlike an ELISA, the MP Diagnostics HELICO BLOT 2.1 allows for the detection of antibodies to specific proteins of H. pylori, including antigens associated with pathology such as CagA and VacA. This kit is supplied for research purposes only. It is not intended for use in the diagnosis or prognosis of disease. In particular, this test cannot be used to evaluate blood specimens for the purpose of donor screening, or as a confirmatory diagnostic.

Helico Blot 2.1 (CE)

The MP Diagnostics HELICO BLOT 2.1 Western Blot kit assay is a qualitative assay for the detection of IgG antibodies to Helicobacter pylori (H. pylori) in human serum or plasma, with the added indication of current status. It is an improved version of HELICO BLOT 2.0 where in addition to bacterial lysate, there is a recombinant antigen with high predictive value for the indication of current H. pylori . The product is intended for use as a serological test for the detection of both current and past with H. pylori. Unlike an ELISA, the MP Diagnostics HELICO BLOT 2.1 allows for the detection of antibodies to specific proteins of H. pylori, including antigens associated with pathology such as CagA and VacA.

HCV Blot 3.0 (RUO)

The MP Diagnostics (MPD) HCV BLOT 3.0 is a qualitative enzyme immunoassay for the in vitro detection of antibodies to HCV in human serum or plasma. This kit is supplied for research use only. It is not intended for use as in the diagnosis or prognosis of disease. In particular, the test cannot be used to evaluate blood specimens for the purpose of donor screening, or as a confirmatory diagnostic.

HCV Blot 3.0 (CE)

The MP Diagnostics HCV BLOT 3.0 is a qualitative enzyme immunoassay for the in vitro detection of antibodies to HCV in human serum or plasma. It is intended for use as a more specific supplemental test on specimens found repeatedly reactive using specific procedures such as ELISA.

HTLV Blot 2.4 (CE)

The MP Diagnostics HTLV BLOT 2.4 is a qualitative enzyme immunoassay for the in vitro detection of antibodies to HTLV-I and HTLV-II in human serum or plasma. It is intended for use as a more specific supplemental test on human serum or plasma specimens found repeatedly reactive using screening procedures like the Enzyme-Linked Immunosorbent Assays (ELISA).

HIV Blot 2.2 (China)

The MP Diagnostics HIV BLOT 2.2 is a qualitative enzyme immunoassay for the in vitro detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) in human serum or plasma. It is intended for use as a more specific supplemental test on human serum or plasma specimens found repeatedly reactive using screening procedures such as the Enzyme-Linked Immunosorbent Assay (ELISA).

HIV Blot 2.2 (RUO)

The MP Diagnostics (MPD) HIV BLOT 2.2 is a qualitative enzyme immunoassay for the in-vitro detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) in human serum or plasma. This test kit is supplied for Research Use Only. It is not intended for use in the diagnosis or prognosis of disease.

HIV Blot 2.2 (CE)

The MP Diagnostics HIV BLOT 2.2 is a qualitative enzyme immunoassay for the in vitro detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) in human serum or plasma. It is intended for use as a more specific supplemental test on human serum or plasma specimens found repeatedly reactive using screening procedures such as the Enzyme-Linked Immunosorbent Assay (ELISA).

HIV-2 Blot 1.2 (RUO)

The MP Diagnostics HIV-2 BLOT 1.2 is a qualitative enzyme immunoassay for in-vitro detection of specific antibodies to HIV-2 in human serum or plasma. This test kit is supplied for research purposes only. It is not intended for use in the diagnosis or prognosis of disease. In particular, this test cannot be used to evaluate blood specimens for the purposes of donor screening or as a confirmatory diagnostic.

HIV-2 Blot 1.2

The MP Diagnostics HIV-2 BLOT 1.2 is a qualitative enzyme immunoassay for the in-vitro detection of specific antibodies to HIV-2 in human serum or plasma. The MP Diagnostics HIV-2 BLOT 1.2 is intended for use as a more specific test on human serum or plasma specimens found to be repeatedly reactive using screening procedures like the Enzyme-Linked Immunosorbent Assay (ELISA).

HIV-1 Blot 1.3 (RUO)

The MP Diagnostics HIV-1 BLOT 1.3 is a qualitative enzyme immunoassay for the in-vitro detection of antibodies to HIV-1 in human serum or plasma. This kit is supplied for research purposes only. It is not intended for use in the diagnosis or prognosis of diseases. In particular, this test cannot be used to evaluate blood specimens for the purpose of donor screening, or as a confirmatory diagnostic.

HIV-1 Blot 1.3 (CE)

The MP Diagnostics HIV-1 BLOT 1.3 is a qualitative enzyme immunoassay for the in-vitro detection of antibodies to HIV-1 in human serum or plasma. It is intended for use as a more specific supplemental test on human serum or plasma specimens found repeatedly reactive using screening procedures such as the Enzyme-Linked Immunosorbent Assay (ELISA).

HIV Blot 2.2

The MP Diagnostics HIV BLOT 2.2 is a qualitative enzyme immunoassay for the in vitro detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) in human serum or plasma. It is intended for use as a more specific supplemental test on human serum or plasma specimens found repeatedly reactive using screening procedures such as the Enzyme-Linked Immunosorbent Assay (ELISA).

HCV Blot 3.0 (China)

The MP Diagnostics HCV BLOT 3.0 is a qualitative enzyme immunoassay for the in vitro detection of antibodies to HCV in human serum or plasma. It is intended for use as a more specific supplemental test on specimens found repeatedly reactive using specific procedures such as ELISA.

AutoScan PRO (CE)

A standardized software system for analysis and interpretation of MP Diagnostics Immunoblot assays. System includes: Plustek S28 Pro Scanner (1 pc), Calibration Card (1 pc), AutoScan PRO Installation CD (1pc), USB license dongle (1pc), AutoScan PRO Analysis Template (5 pcs)

AutoBlot System 20 (CE)

A fully automated, self-contained instrument for performing MP Diagnostics Immunblot assays.

htlv-blot-2.4-0711088036

HTLV Blot 2.4 (FDA)

The MP Diagnostics HTLV Blot 2.4 is intended as a supplemental (additional more specific), test to confirm the presence of anti-HTLV-I/II antibodies in blood donor specimens repeatedly reactive on an FDA licensed screening test and to differentiate between HTLV type-I and HTLV type-II infections for donor notification and counseling. The possible serological profiles defined by the HTLV Blot 2.4 include the following: HTLV-I Seropositive, HTLV-II Seropositive, HTLV-I/II Seropositive, Seronegative and Indeterminate. The MP Diagnostics HTLV Blot 2.4 uses a combination of HTLV-I/II genetically engineered proteins (i.e., recombinant antigens) and HTLV-I viral proteins derived from native, inactivated viral particles (i.e., viral lysate). The differentiation between HTLV-I and HTLV-II is accomplished through the use of rgp46-I, a unique HTLV-I envelope recombinant protein, and rgp46-II, a unique HTLV-II envelope recombinant protein. Both proteins are derived from the central region of the external glycoprotein, gp46, of HTLV-I and HTLV-II respectively. GD21, a common yet specific HTLV-I and HTLV-II epitope envelope recombinant protein derived from a truncated region of p21e (rgp21), is also used to enhance the specificity of envelope antibody detection: GD21 has demonstrated better specificity over p21e73, an earlier version of the recombinant antigen. The antigenicity exhibited by these recombinant proteins is either common to HTLV-I and HTLV-II antibodies or type specific to one of the two viral types to allow confirmation and differentiation in a single assay. Additional differentiation between HTLV viral types is effected using gag proteins p19 and p24; if p19 is greater than or equal to p24, HTLV-I infection is suggested, and if p24 is greater than p19, HTLV-II infection is suggested.

  • 1